• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Avelas Biosciences

edit

At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.

Recent Milestones

edit

• 
  Avelas Biosciences received $7.65M in Series A funding. (12/6/12)
  Posted 12/7/12 at 9:55pm via prnewswire.com

Videos

Screenshots

edit

Above: Avelas Biosciences
Uploaded: 12/8/12

Sources

1. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development (prnewswire.com) [edit]